Announcements

ReACH/IIMS Announce 2019-2020 Population Health Pilot Grants Program

The ReACH Center, in conjunction with the Institute for Integration of Medicine and Science (IIMS) have announced the 2019-2020 ReACH/IIMS Population Health Pilot Grants Program.  Applications are due January 13, 2020 by 5:00 pm.  To learn more about this RFA please visit our ReACH/IIMS Popultion Health Pilot Grants page! 

ReACH is Seeking a Research Area Specialist!

The ReACH Center is recruiting for a Research Area Specialist-Associate position.  For more information about this opening, please visit our Staff Opportunites page.  

Become a Member of the ReACH Center

Do you have an interest in the health of San Antonio and the South Texas region?  Become a member of the ReACH Cenrer!  Membership is free provides the opportunity to get involved with shaping the future of population health, clinical and translational research in South Texas!  For more information and to sign up click here!

Contact Us

7411 John Smith Road

Suite 1050

San Antonio, TX

78229

 

Tel: 210-562-5551

Fax: 210-562-5560

STOP HCC/HCV Program Featured in CPRIT Annual Report

The Cancer Prevention & Research Institute of Texas (CPRIT) featured the STOP HCC/HCV program in their 2018 annual report . The Screen, Treat Or Prevent (STOP) HCC/HCV program has been funded by CPRIT since May 2015 and is led by former ReACH Director Barbara J. Turner, MD, MSEd. In partnership with the University of Texas Southwestern Medical Center, STOP HCC/HCV focuses on the prevention of liver cancer through the screening and diagnosis of hepatitis C (HCV). This important work is accomplished through community education and the implementation of preventive HCV screening for baby boomers in primary care practices across Dallas and South Texas. The program also provides patient navigation and treatment support for uninsured patients found to be chronically infected with HCV. The STOP HCC/HCV project was recently awarded a CPRIT Expansion grant to expand the project to West Texas with an increased focus on identifying patients outside of the baby boomer birth cohort who need to be treated for HCV to reduce their risk for developing liver cancer. Visit the STOP HCC/HCV website to learn more about this important program working to end the liver cancer epidemic in Texas.